Latest News about CMPS

Recent news which mentions CMPS

< Previous 1 2 3 4 5 6 7 8 9

...

Compass Pathways Plc (CMPS) Q1 2024 Earnings Call Transcript

May 09, 2024

CMPS Stock Earnings: Compass Pathways Misses EPS for Q1 2024

May 08, 2024

Jim Cramer Slams Political Blocking Of 'LSD-Derived Antidepressants,' Citing Strong Test Data 'Showing They Worked'

April 19, 2024

Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More

April 17, 2024

Who's Who In Cannabis: Latest Executive Changes You Should Know About

April 15, 2024

Micron, Iris Energy, Trip.com Group And Other Big Stocks Moving Higher On Monday

April 01, 2024

Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More

March 30, 2024

Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence

March 29, 2024

Atai Life Sciences Q4 And Full-Year 2023 Results: Steep Cash Drain Yet 2026 Target Remains, Update On Psychedelic Pipeline

March 29, 2024

Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More

March 20, 2024

FDA Grants Cybin Breakthrough Therapy Status For Major Depression Psilocybin Therapy, Company Announces Positive Clinical Data & Canadian $150M Private Placement

March 13, 2024

MindMed Receives FDA 'Breakthrough Therapy' Designation For LSD As Anxiety Treatment, Shares Positive Results About Related Clinical Trials

March 07, 2024

Psychedelics 2024: Veterans Blessing, Mental Health Paradigm Shift, Providers Training, Ketamine-MDMA Bonds & More

March 06, 2024

3 Biopharma Stocks You Don't Want to Miss in the New Bull Market

March 05, 2024

Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More

March 04, 2024

Compass Pathways Plc (CMPS) Q4 2023 Earnings Call Transcript

February 29, 2024

Compass Pathways Shows Robust 2023 Year-End Results, Embraces Clinical Milestones For Psilocybin As Depression Treatment

February 29, 2024

Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

February 29, 2024

Podcast - Post-Frenzy Psychedelics Investing And Reclaiming The Right To Pursue Happiness With Zappy Zapolin: '2024 Is When It Goes Mainstream'

February 29, 2024

Earnings Scheduled For February 29, 2024

February 29, 2024

Earnings Preview For Compass Pathways

February 28, 2024

Penny Power Players: 3 Stocks to Watch in the Microcap Arena

February 27, 2024

Mental Health Mavericks: 3 Stocks Changing the Game

February 21, 2024

Wall Street Says Compass Pathways Could Rise 307%. Here's How It Could Actually Happen.

February 19, 2024

Psyched: Psychedelics & Sex, MDMA And Federal Approval, Canadians For End-Of-Life Care And More

February 15, 2024

Why Is MindMed (MNMD) Stock Up 8% Today?

February 12, 2024

Psilocybin Mushrooms For Sale: Is It Legal Anywhere In America?

February 02, 2024

Psyched: Suggestibility And Psychedelics' Effects, EU's $7M Research Fund, Australia's Treatment Delivery, BZ Podcast And More

January 27, 2024

Psychedelics Headlines: Anti-inflammatory Effects, Global Drug Survey, 'Synthetic Surprise,' UK's Harm Reduction Hub And More

January 26, 2024

New Study Reveals Suggestibility's Role In Antidepressant Effects Of Psilocybin Therapy

January 25, 2024

< Previous 1 2 3 4 5 6 7 8 9

...

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.